Hepion Pharmaceuticals, Inc. (HEPA) earnings
HEPA earnings moved a median of +0.28% by the close. Quarterly and annual HEPA reports and results, each read against the price at its own news timestamp. Back to the HEPA overview →
19 measured HEPA earnings events.
Where these HEPA earnings landedvs 18 measured HEPA earnings reactions
| Middle 50% of HEPA earnings reactions | -1.74% to +3.69% |
|---|---|
| Median reaction (to close) | +0.28% |
| Measured reactions | 18 |
Point-in-time · zero look-ahead
Half of the 18 HEPA earnings events with a measured close landed between -1.74% and +3.69%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Hepion Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.11% | |
| Form 10-Q Hepion Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.56% | |
| Form 10-K Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.00% | |
| Form 10-Q Hepion Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q Hepion Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-Q Hepion Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.06% | -13.83% | |
| Form NT 10-Q Hepion Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | +0.00% | -10.32% | |
| Form 10-K Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.02% | +8.40% | |
| Form NT 10-K Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | +2.90% | +12.76% | |
| Form 10-K/A Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -6.98% | |
| Form 10-Q Hepion Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | — | +3.42% | |
| Form 10-Q Hepion Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 10-K/A Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | — | +3.77% | |
| Form 10-Q Hepion Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.00% | |
| Form NT 10-Q Hepion Pharmaceuticals, For: Mar 31 | SEC filing · Form NT | +10.81% | +9.73% | |
| Form 10-K Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | — | +1.91% | |
| Form NT 10-K Hepion Pharmaceuticals, For: Dec 31 | SEC filing · Form NT | +0.00% | -4.18% | |
| Form 10-Q Hepion Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +2.29% | +1.63% | |
| Form NT 10-Q Hepion Pharmaceuticals, For: Sep 30 | SEC filing · Form NT | +1.35% | -2.32% |
Keep exploring
More HEPA: analyst actions → · SEC filings → · HEPA overview →